Thursday, October 8, 2009

Pharmaceutical kept information from doctors in order to market drug

Internal documents disclosed during the litigation over Seroquel suggest that AstraZeneca continued to promote the antipsychotic drug as weight neutral, years after clinical evidence demonstrated significant Seroquel weight gain problems for users, which could lead to diabetes and other serious side effects. For the full story (with lots of links to more info) go here.

No comments: